John Hopper

Chairman

John Hopper is the Founding Co-Chair of the GI Cancers Alliance, Founding Co-Chair of NORD (National Organization Rare Disorders) Rare Cancer Coalition; Advisory Board Director- Fred Hutch TRACER Program; Executive Board Director -SARC (Sarcoma); Advisory Board Director- KHORA Bio Tech; Former President of the Fibrolamellar Cancer Foundation, Inaugural member of the Chan Zuckerberg Initiative (CZI) Rare as One Network; Former Board Director of the National Pancreas Foundation; and Founder of the Patient Activation Group.  Before his focus on health care foundations, John created and led multibillion-dollar revenue centers as well as start-ups and turn-arounds across numerous industry verticals with an emphasis on health/wellness, digital/interactive, consumer goods, environment, and technology nationally and internationally. John launched profitable divisions and products for such companies as the WPP Group, Interpublic (IPG), Unilever, P&G, and Publicis and spearheaded complex international cross-disciplinary management teams. He has held various board positions within digital companies and co-founded wellness venture capital and renewable energy mobilization firms. His experience also includes: Adjunct Professor, NYU Stern Graduate School of Business, US Department of Defense – Pancreatic and Rare Cancer CDMRP Advisory Board; National Cancer Institute (NIH/NCI) Small Business Advisor Board and MyPART; State of Connecticut Business Health Council- Office of Secretary of State; University of Connecticut – Environmental Health Academic Internship leader

Hopper is a graduate of the College of the Holy Cross and the Unilever/Oxford Executive MBA program.